Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1200/JCO.2022.40.4\_suppl.202
dc.identifier.other
WOS:000770995900198
dc.description.volume
dc.description.issue
Publisher
LIPPINCOTT WILLIAMS \& WILKINS
DOI
10.1200/JCO.2022.40.4\_suppl.202
Abstract
ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, JAN 20-22, 2022